You are here: Industry Insights > oncology drug

News List

Sterling Pharma Solutions signs up to manufacture OncoTEX's ovarian cancer drug cphi-online
May 24, 2021
The CDMO's expertise and capabilities a "perfect fit" for overcoming the challenges of manufacturing this complex molecule
AztraZeneca to launch oncology drug Calquence in India expresspharma
October 19, 2020
AstraZeneca Pharma India has received import and market permission in Form CT-20 (Marketing Authorization- Additional Indication) from the Drugs Controller General of India for Acalabrutinib 100 mg capsules (Calquence ).
Bayer and Exscientia collaborate to leverage the potential of artificial intelligence in cardiovascular and oncology drug discovery worldpharmanews
January 14, 2020
Bayer and Exscientia Ltd., a UK-based Artificial Intelligence (AI)-driven drug discovery company, have entered into a three-year, multi-target collaboration.
Sanofi defends top oncology drug with Jevtana patent win fiercepharma
August 18, 2019
Sanofi and generic drugmakers have been battling back and forth over patents protecting the company’s top oncology product, Jevtana. In the latest round, Sanofi proved victorious.
Roche gets approval for oncology drug, Rozlytrek biospectrumasia
August 18, 2019
FDA Approves Genentech’s Personalized Medicine for Two Different Indications in ROS1-Positive Non-Small Cell Lung Cancer and NTRK Fusion-Positive Solid Tumors
Lupin and AbbVie Announce Partnership to Develop and Commercialize Novel Oncology Drug to Treat Hematological Cancers pharmafocusasia
December 27, 2018
Pharma major Lupin Limited (Lupin) and global biopharmaceutical company AbbVie Inc., today announced that AbbVie has licensed Lupin’s MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1) inhibitor program......
J&J shares fall after court refuses to block Zytiga generics pharmaphorum
November 27, 2018
Johnson & Johnson’s share price took a beating this week after the US appeals court declined its bid to stop sales of cheap generic versions of its blockbuster prostate cancer drug Zytiga.
Xynomic Pharma completes series B financing biospectrumasia
June 04, 2018
The Series B proceeds will be used to initiate eight clinical trials, four of which are pivotal, in the next 12 months.
Oncology Drug Market: A Spotlight on the Dynamics biospectrumasia
March 26, 2018
Cancer is one the most dreaded diseases worldwide and is spreading like a pandemic in Asia- Pacific region.
Oncology Drug Market Size to Approach USD 200 Billion: Changing Giants, Same Roche en-cphi.cn
July 14, 2017
The authoritative research report on the pharmaceutical industry recently issued by EvaluatePharma and IMS Health has made in-depth analysis and forecast for the pharmaceutical industry and global oncology drug development trends.